Mark G. Bock
165 works · 5,486 citations · h-index 36
Top works
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
- Protection of primary hydroxyl groups as methylthiomethyl ethers
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260
- A simple and highly effective route to α,β-unsaturated aldehydes
- Total synthesis of (.+-.)-N-methylmaysenine
- Synthesis and resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones
- Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists
- Stereocontrolled route to a key intermediate for the synthesis of maytansine
- 1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor
- A new amine resolution method and its application to 3-aminobenzodiazepines
- Development of 1,4-benzodiazepine cholecystokinin type B antagonists
- Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position
- Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
- L‐368,899, a potent orally active oxytocin antagonist for potential use in preterm labor
- Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues
- Design and Synthesis of Novel α1a Adrenoceptor-Selective Antagonists. 2. Approaches To Eliminate Opioid Agonist Metabolites via Modification of Linker and 4-Methoxycarbonyl-4-phenylpiperidine Moiety
- Total synthesis of nonpeptidal cholecystokinin antagonists from Aspergillus alliaceus
- A key intermediate for the synthesis of maytansine and related antitumor agents
- An expedient synthesis of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one